Biomedical Issues of Dietary fiber beta-Glucan.
10.3346/jkms.2006.21.5.781
- Author:
Soo Young KIM
1
;
Hong Ji SONG
;
Yoon Young LEE
;
Kyung Hwan CHO
;
Yong Kyun ROH
Author Information
1. Department of Family Medicine, Hallym University, College of Medicine, Chunchon, Korea. rohyk@hallym.ac.kr
- Publication Type:Review ; Research Support, Non-U.S. Gov't
- Keywords:
beta-Glucans;
Cholesterol;
Glucose;
Weight Loss;
Weight Reductions;
Anticarcinogenic Agents
- MeSH:
beta-Glucans/administration & dosage/*pharmacology/therapeutic use;
Neoplasms/drug therapy;
Infection/drug therapy;
Humans;
Dose-Response Relationship, Drug;
Dietary Supplements;
Dietary Fiber/administration & dosage/*pharmacology/therapeutic use;
Cholesterol/blood;
Body Weight/drug effects;
Blood Glucose/analysis;
Anticholesteremic Agents/pharmacology;
Animals
- From:Journal of Korean Medical Science
2006;21(5):781-789
- CountryRepublic of Korea
- Language:English
-
Abstract:
beta-Glucan is a polysaccharide in the form of fiber and the main element of fiber in grains such as barley, oats, yeast and mushrooms. Many studies have examined the efficacy of beta-Glucan in terms of the lipid lowering effects, blood sugar reduction, weight reduction, immune modulator, and anticarcinogenic effect. However, there is no comprehensive review article on the biomedical issues regarding beta-Glucan. The authors searched for systematic reviews and clinical experiments for each relevant topic and reviewed the biomedical effects of beta-Glucan, for the purpose of developing research strategies for the future.
